Shashi N Kapadia, MD

Associate Professor of Medicine

Infectious Diseases (Medicine)

Contact & profiles

Appointments

Associate Professor of MedicinePrimary
Medicine · 2026–
Associate Professor of Population Health Sciences
Population Health Sciences · 2026–
Assistant Professor
Weill Cornell Graduate School — Clinical & Translational Investigation · 2025–
Physician- Medicine
NewYork-Presbyterian Hospital

Past Appointments

Assistant Professor of Medicine
Medicine · 2020–2025
Assistant Professor of Population Health Sciences
Population Health Sciences · 2020–2025
Instructor in Medicine
Medicine · 2017–2020

Show all 7

Instructor in Healthcare Policy and Research
Population Health Sciences · 2017–2018
Fellow in Healthcare Policy and Research
Population Health Sciences · 2015–2017
Fellow in Medicine
Medicine · 2015–2017
Fellow in Medicine
Medicine · 2014–2015

Centers

Education

M.S.
Weill Cornell Graduate School of Medical Sciences, 2017
M.D.
New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 2011
B.A.
New York University, 2007

Highlights

1
JAMA network open · 2023
SNShashi N Kapadia CGChristopher Gonzalez YBYuhua Bao MSMartin Shapiro
PMID: 37540513PMCID: PMC10403776DOIFirst author30 citations
2
Harm reduction journal · 2023
SNShashi N Kapadia KMKristen Marks
PMID: 37501180PMCID: PMC10375754DOIFirst author17 citations
3
Journal of general internal medicine · 2021
SNShashi N Kapadia BSBruce Schackman CNCzarina Navos Behrends
PMID: 33469774PMCID: PMC7815286DOIFirst author37 citations

6 grants

KP
Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
National Institute of Allergy and Infectious Diseases · 2026–2031 · via Columbia University
P30AI191337-01A1
PI
Universal HCV screening in pregnancy: Examining testing uptake and HCV care
National Institute on Drug Abuse · 2024–2029
R01DA060499-03
Co-I
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network - CTN0121
National Institute on Drug Abuse · 2021–2028 · via University of Miami· 2 renewals
UG1DA013720-26S3
PI
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections
National Institute on Drug Abuse · 2023–2027
R01DA057940-04
Co-I
The Continuum of Care in Hospitalized patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE): Multi-center Clinical Trial
National Institutes of Health, Clinical Center · 2024–2026 · via University of Maryland
75N90023C00013
Co-I
Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections
National Institute on Drug Abuse · 2020–2026 · via University of Kentucky
R01DA048892-01A1

Completed grants (5)

PI
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment
National Institute on Drug Abuse · 2019–2025Career· 2 renewals
K01DA048172-05
Sub-PI
Cost-effectiveness and Clinical Outcomes of Liver Disease Staging Evaluations in Chronic Hepatitis C Virus Infection: Strategies to Increase Hepatitis C Treatment Access
Patrick and Catherine Weldon Donaghue Medical Research Foundation · 2022–2024 · via Boston Medical Center (Corporation)
BMC 220094-02
Co-I
DAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service Programs
National Institute on Drug Abuse · 2019–2024
R01DA027379-07
PI
Epidemiology and outcomes of serious injection-related infections in New York State
New York State Department of Health · 2022–2023
DOH01-T37781GG-3450000
Co-I
Evaluation of Community-based Drug User Health Hubs to Reduce Opioid Overdoses in NY State
Centers for Disease Control and Prevention · 2018–2022 · via Health Research INC (Center for Community Health)
5 R01 CE00302202-02

1 study

PI
Universal HCV screening in pregnancy: Examining testing uptake and HCV care
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)

Completed & closed trials (1)

PI
Individual patient expanded access of REGEN-CoV Investigational New Drug Application (sIND)
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2022)

Initiation of Hepatitis C Treatment Low Among Medicaid Recipients
August 4, 2023
While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.